Studija slučaja
https://doi.org/10.20471/sept.2026.62.02.09
Escitalopram induced Galactorrhea: a Case Series Emphasizing Delayed Onset in Long Term Therapy
Aijaz Mohiuddin Bhat
; Odjel za psihijatriju, Državni medicinski fakultet Baramulla, Baramulla, Indija
*
Nizam ud din Dar
; Odjel za psihijatriju, Sher-i-Kashmir Institute of Medical Sciences, MCH Bemina, Indija
Abdul Majid Gania
; Odjel za psihijatriju, Sher-i-Kashmir Institute of Medical Sciences, MCH Bemina, Indija
* Dopisni autor.
Sažetak
Background: Escitalopram, a widely used psychotropic (SSRI) used for depression, has rarely been associated with hyperprolactinemia and galactorrhea. Current literature at present has isolated case reports, with no prior series documenting this adverse effect after prolonged use. Aim: To present four cases of symptomatic hyperprolactinemia and galactorrhea with onset after 2 – 3 years of escitalopram monotherapy. Case reports: This case series is a retrospective analysis of four female patients aged between 27 – 58 years presenting to our OPD SKIMS MCH Bemina Srinagar with bilateral galactorrhea under escitalopram treatment (10 – 20 mg/day). Organic causes were ruled out via comprehensive workup from different departments (serum β - hCG, TSH, MRI brain, USG breasts/pelvis). Serum prolactin levels were measured on presentation and after discontinuation of the SSRI. Patients developed galactorrhea after 2 – 3 years of dose range: 10 – 20 mg/day, having prolactin levels that ranged from 202 – 322 ng/mL, in which resolution occurred within 4 – 8 weeks after discontinuation. Conclusion: Escitalopram can induce delayed-onset hyperprolactinemia and galactorrhea after prolonged use, even at standard doses. Patients on SSRIs should be evaluated for galactorrhea irrespective of duration and dosage. A strategy should be devised for early pickup.
Ključne riječi
Escitalopram; hyperprolactinemia; galactorrhea; case reports
Hrčak ID:
352982
URI
Datum izdavanja:
16.10.2026.
Posjeta: 0 *